[Hepatotoxicity of non-steroidal anti-inflammatory drugs].
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury; D002648:Child; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects; D008099:Liver / Q000187:drug effects*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010648:Phenylacetates / Q000009:adverse effects; D010666:Phenylpropionates / Q000009:adverse effects; D011720:Pyrazoles / Q000009:adverse effects; D011758:Pyrroles / Q000009:adverse effects; D012459:Salicylates / Q000009:adverse effects; D013467:Sulindac / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D007211:Indoles; D010648:Phenylacetates; D010666:Phenylpropionates; D011720:Pyrazoles; D011758:Pyrroles; D012459:Salicylates; D013467:Sulindac; D001241:Aspirin
L'epatotossicità dei farmaci antiinfiammatori non steroidei (NSAID).